Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04941456 · ClinicalTrials.gov registry record · NA
Does Endurance Improve With the Use of Passy-Muir Valve for Patients With Tracheostomy?
A NA study, sponsored by Gaylord Hospital.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04941456: Completed NA study, sponsored by Gaylord Hospital.
NCT04941456 is a NA study that has completed, run by Gaylord Hospital. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04941456, a NA study, has completed, sponsored by Gaylord Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of the Passy-Muir Valve improves endurance for patients in the Long Term Acute Care setting as measured with the Six- Minute Walk Test.
Primary Outcome
During each session, Participants will be asked to walk as far as possible along a corridor for a period of six minutes. The distance the Participant walks will be recorded to compare if the Participant can walk further with or without the PMV in place. Participant can use a device to assist with balance and the Participant can be assisted by an investigator, if needed. Each session is scheduled in an alternating fashion for whether or not Participant will use the PMV (i.e. day one no PMV, day t
Interventions
- OTHER Open Tracheostomy
- DEVICE PMV in place
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2021-07-29 |
| Est. Completion | 2024-06-24 |
| Phase | NA |
What the finished NCT04941456 record still lists
NCT04941456 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Open Tracheostomy is the first listed.
NCT04941456 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04941456 about?
NCT04941456 is a clinical study titled "Does Endurance Improve With the Use of Passy-Muir Valve for Patients With Tracheostomy?". The purpose of this study is to determine if the use of the Passy-Muir Valve improves endurance for patients in the Long Term Acute Care setting as measured with the Six- Minute Walk Test.
What is the current status of trial NCT04941456?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2021-07-29. Estimated completion is 2024-06-24.
What interventions are being tested in trial NCT04941456?
The interventions under investigation include: Open Tracheostomy (OTHER), PMV in place (DEVICE).
Who is sponsoring clinical trial NCT04941456?
This trial is sponsored by Gaylord Hospital, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04941456's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI